{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:10:22Z","timestamp":1780081822079,"version":"3.54.0"},"reference-count":21,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi231106-4\"><jats:title>Importance<\/jats:title><jats:p>It is currently unclear whether high-resolution computed tomography can preoperatively identify pathologic tumor invasion for ground-glass opacity lung adenocarcinoma.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231106-5\"><jats:title>Objectives<\/jats:title><jats:p>To evaluate the diagnostic value of high-resolution computed tomography for identifying pathologic tumor invasion for ground-glass opacity featured lung tumors.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231106-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This prospective, multicenter diagnostic study enrolled patients with suspicious malignant ground-glass opacity nodules less than or equal to 30 mm from November 2019 to July 2021. Thoracic high-resolution computed tomography was performed, and pathologic tumor invasion (invasive adenocarcinoma vs adenocarcinoma in situ or minimally invasive adenocarcinoma) was estimated before surgery. Pathologic nonadenocarcinoma, benign diseases, or those without surgery were excluded from analyses; 673 patients were recruited, and 620 patients were included in the analysis. Statistical analysis was performed from October 2021 to January 2022.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231106-7\"><jats:title>Exposure<\/jats:title><jats:p>Patients were grouped according to pathologic tumor invasion.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231106-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Primary end point was diagnostic yield for pathologic tumor invasion. Secondary end point was diagnostic value of radiologic parameters.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231106-9\"><jats:title>Results<\/jats:title><jats:p>Among 620 patients (442 [71.3%] female; mean [SD] age, 53.5 [12.0] years) with 622 nodules, 287 (46.1%) pure ground-glass opacity nodules and 335 (53.9%) part-solid nodules were analyzed. The median (range) size of nodules was 12.1 (3.8-30.0) mm; 47 adenocarcinomas in situ, 342 minimally invasive adenocarcinomas, and 233 invasive adenocarcinomas were confirmed. Overall, diagnostic accuracy was 83.0% (516 of 622; 95% CI, 79.8%-85.8%), diagnostic sensitivity was 82.4% (192 of 233; 95% CI, 76.9%-87.1%), and diagnostic specificity was 83.3% (324 of 389; 95% CI, 79.2%-86.9%). For tumors less than or equal to 10 mm, 3.6% (8 of 224) were diagnosed as invasive adenocarcinomas. The diagnostic accuracy was 96.0% (215 of 224; 95% CI, 92.5%-98.1%), diagnostic specificity was 97.2% (210 of 216; 95% CI, 94.1%-99.0%); for tumors greater than 20 mm, 6.9% (6 of 87) were diagnosed as adenocarcinomas in situ or minimally invasive adenocarcinomas. The diagnostic accuracy was 93.1% (81 of 87; 95% CI, 85.6%-97.4%) and diagnostic sensitivity was 97.5% (79 of 81; 95% CI, 91.4%-99.7%). For tumors between 10 to 20 mm, the diagnostic accuracy was 70.7% (220 of 311; 95% CI, 65.3%-75.7%), diagnostic sensitivity was 75.0% (108 of 144; 95% CI, 67.1%-81.8%), and diagnostic specificity was 67.1% (112 of 167; 95% CI, 59.4%-74.1%). Tumor size (odds ratio, 1.28; 95% CI, 1.18-1.39) and solid component size (odds ratio, 1.31; 95% CI, 1.22-1.42) could each independently serve as identifiers of pathologic invasive adenocarcinoma. When the cutoff value of solid component size was 6 mm, the diagnostic sensitivity was 84.6% (95% CI, 78.8%-89.4%) and specificity was 82.9% (95% CI, 75.6%-88.7%).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231106-10\"><jats:title>Conclusions and relevance<\/jats:title><jats:p>In this diagnostic study, radiologic analysis showed good performance in identifying pathologic tumor invasion for ground-glass opacity\u2013featured lung adenocarcinoma, especially for tumors less than or equal to 10 mm and greater than 20 mm; these results suggest that a solid component size of 6 mm could be clinically applied to distinguish pathologic tumor invasion.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.37889","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T15:33:06Z","timestamp":1697470386000},"page":"e2337889","source":"Crossref","is-referenced-by-count":17,"title":["Radiologic Identification of Pathologic Tumor Invasion in Patients With Lung Adenocarcinoma"],"prefix":"10.1001","volume":"6","author":[{"given":"Ting","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China"},{"name":"Institute of Thoracic Oncology, Fudan University, Shanghai, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxuan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China"},{"name":"Institute of Thoracic Oncology, Fudan University, Shanghai, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengping","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"},{"name":"Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"},{"name":"Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajia","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"},{"name":"Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The Second Hospital of Liaocheng Affiliated to Shandong First Medical University, Linqing, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqiang","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Jiangdu People\u2019s Hospital of Yangzhou, Yangzhou, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China"},{"name":"Institute of Thoracic Oncology, Fudan University, Shanghai, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China"},{"name":"Institute of Thoracic Oncology, Fudan University, Shanghai, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihua","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China"},{"name":"Institute of Thoracic Oncology, Fudan University, Shanghai, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China"},{"name":"Institute of Thoracic Oncology, Fudan University, Shanghai, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqing","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China"},{"name":"Institute of Thoracic Oncology, Fudan University, Shanghai, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"},{"name":"Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuxia","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"},{"name":"Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zezhou","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"},{"name":"Department of Cancer Prevention, Fudan University Shanghai Cancer Center, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiquan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China"},{"name":"Institute of Thoracic Oncology, Fudan University, Shanghai, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"issue":"5","key":"zoi231106r1","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening.","volume":"365","author":"Aberle","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi231106r2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1056\/NEJMoa1301851","article-title":"Targeting of low-dose CT screening according to the risk of lung-cancer death.","volume":"369","author":"Kovalchik","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi231106r3","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.athoracsur.2020.04.094","article-title":"Management of ground-glass opacities in the lung cancer spectrum.","volume":"110","author":"Zhang","year":"2020","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"zoi231106r4","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","article-title":"International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma.","volume":"6","author":"Travis","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"9","key":"zoi231106r5","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification.","volume":"10","author":"Travis","year":"2015","journal-title":"J Thorac Oncol"},{"issue":"3","key":"zoi231106r6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of lung tumors: impact of advances since 2015.","volume":"17","author":"Nicholson","year":"2022","journal-title":"J Thorac Oncol"},{"issue":"2","key":"zoi231106r7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.lungcan.2015.06.022","article-title":"Prognostic value of the new IASLC\/ATS\/ERS classification of clinical stage IA lung adenocarcinoma.","volume":"90","author":"Murakami","year":"2015","journal-title":"Lung Cancer"},{"issue":"1","key":"zoi231106r8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jtcvs.2013.08.058","article-title":"Tumor invasiveness as defined by the newly proposed IASLC\/ATS\/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.","volume":"147","author":"Takahashi","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"8","key":"zoi231106r9","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.jtho.2021.04.007","article-title":"Long-term prognosis of patients with resected adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung.","volume":"16","author":"Yotsukura","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"6","key":"zoi231106r10","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.jtcvs.2022.06.017","article-title":"Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: wedge resection is curative.","volume":"164","author":"Li","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"zoi231106r11","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.athoracsur.2018.06.058","article-title":"Predictors of pathologic tumor invasion and prognosis for ground glass opacity featured lung adenocarcinoma.","volume":"106","author":"Ye","year":"2018","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"zoi231106r12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/JTO.0b013e31821038ab","article-title":"A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201).","volume":"6","author":"Suzuki","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"1","key":"zoi231106r13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jtcvs.2012.12.047","article-title":"Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201.","volume":"146","author":"Asamura","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"zoi231106r14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1148\/radiol.2017161659","article-title":"Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017.","volume":"284","author":"MacMahon","year":"2017","journal-title":"Radiology"},{"issue":"1","key":"zoi231106r16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J Thorac Oncol"},{"issue":"1","key":"zoi231106r17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jtcvs.2020.09.146","article-title":"A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer.","volume":"163","author":"Suzuki","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"zoi231106r18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1200\/JCO.2015.63.4907","article-title":"Precise diagnosis of intraoperative frozen section is an effective method to guide resection strategy for peripheral small-sized lung adenocarcinoma.","volume":"34","author":"Liu","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi231106r19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.lungcan.2015.07.007","article-title":"Association between high-resolution computed tomography findings and the IASLC\/ATS\/ERS classification of small lung adenocarcinomas in Japanese patients.","volume":"90","author":"Kudo","year":"2015","journal-title":"Lung Cancer"},{"issue":"4","key":"zoi231106r20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cllc.2020.01.014","article-title":"A subsolid nodules imaging reporting system (SSN-IRS) for classifying 3 subtypes of pulmonary adenocarcinoma.","volume":"21","author":"Cui","year":"2020","journal-title":"Clin Lung Cancer"},{"issue":"8","key":"zoi231106r21","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.jtho.2016.03.025","article-title":"The IASLC Lung Cancer Staging Project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM classification of lung cancer.","volume":"11","author":"Travis","year":"2016","journal-title":"J Thorac Oncol"},{"key":"zoi231106r15","volume-title":"Thoracic Tumours","author":"World Health Organization","year":"2021","edition":"5th ed"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2810669\/ye_2023_oi_231106_1696606514.95347.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T15:33:09Z","timestamp":1697470389000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2810669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.37889","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,16]]}}}